Matricelf Ltd - Asset Resilience Ratio

Latest as of December 2024: 64.57%

Matricelf Ltd (MTLF) has an Asset Resilience Ratio of 64.57% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MTLF total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ILA11.85 Million

≈ $31.77K USD Cash + Short-term Investments

Total Assets

ILA18.35 Million

≈ $49.20K USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Matricelf Ltd's Asset Resilience Ratio has changed over time. See net assets of Matricelf Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Matricelf Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MTLF company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA11.85 Million	64.57%
Total Liquid Assets	ILA11.85 Million	64.57%

Asset Resilience Insights

Very High Liquidity: Matricelf Ltd maintains exceptional liquid asset reserves at 64.57% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Matricelf Ltd Industry Peers by Asset Resilience Ratio

Compare Matricelf Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	30.29%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Shanghai Junshi Biosciences Co Ltd SHG:688180	Biotechnology	4.28%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	83.49%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	41.74%

Annual Asset Resilience Ratio for Matricelf Ltd (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Matricelf Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	64.57%	ILA11.85 Million ≈ $31.77K	ILA18.35 Million ≈ $49.20K	-5.27pp
2023-12-31	69.84%	ILA21.09 Million ≈ $56.55K	ILA30.20 Million ≈ $80.98K	-9.01pp
2022-12-31	78.85%	ILA31.14 Million ≈ $83.49K	ILA39.49 Million ≈ $105.88K	--

pp = percentage points

About Matricelf Ltd

TA:MTLF Israel Biotechnology

Market Cap

$23.72 Million

ILA8.85 Billion ILA

Market Cap Rank

#24493 Global

#354 in Israel

Share Price

ILA302.50

Change (1 day)

+5.84%

52-Week Range

ILA204.30 - ILA785.80

All Time High

ILA1480.00